ClinicalTrials.Veeva

Menu

Peripheral Nerve Stimulation to Reduce Hypoxic Events

Mayo Clinic logo

Mayo Clinic

Status

Completed

Conditions

Hypoventilation
Apnea
Hypoxemia

Treatments

Device: Stimulator sham Device
Device: Stimulator active device

Study type

Interventional

Funder types

Other

Identifiers

NCT02554110
13-003533

Details and patient eligibility

About

This study is designed to determine if using peripheral nerve stimulation in conjunction with pulse oximetry as an adjunct to traditional monitoring in the PACU reduces the frequency and severity of sedation related apnea and hypoxic events.

Full description

The primary effectiveness objective is to determine if transcutaneous stimulation will generate a respiratory response capable of reducing the extent and duration of oxygen desaturations in patients with presumed risk of obstructive sleep apnea (OSA) who have received some form of anesthesia or sedation. The primary safety objective is the demonstration that the peripheral nerve stimulation is safe for the use of preventing or reducing the sedation related hypoxemic events.

Enrollment

80 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • Males and females > 18 yrs old
  • Flemon's Score > 15
  • Able to provide written informed consent
  • Having gynecological, colorectal, orthopedic surgery, and urologic surgeries
  • Baseline oxygen saturation on room air > 96%

Exclusion Criteria:

  • Peripheral neuropathy involving the upper extremities
  • Procedures requiring direct admission to the ICU or any site other than the post-anesthesia care unit from the OR
  • Diagnosed obstructive sleep apnea (OSA) and / or use of continuous positive airway pressure (CPAP) or biphasic positive airway pressure (BiPAP) in the PACU.
  • Presence of any implantable electric devices, including internal defibrillators, pacemakers, or left ventricular assist device (LVAD)
  • Post-procedure temperature < 35.5 Celsius or evidence of vasoconstriction
  • Presence of metal hardware in either arm or in either shoulder
  • Patients lacking access to the bare skin on an arm after surgery.
  • History of atrial fibrillation
  • History of bundle branch block
  • Females from menarche to menopause that do not have a current negative pregnancy test or surgical history preventing pregnancy.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

80 participants in 2 patient groups

Stimulator Active Device
Experimental group
Description:
Intervention: This intervention arm will use a Stimulator Active Device peripheral nerve stimulation. Participants will receive a cutaneous stimuli in response to oxygen desaturations in postoperative surgical patients.
Treatment:
Device: Stimulator active device
Stimulator Sham Device
Sham Comparator group
Description:
No intervention: This arm will use a Stimulator Sham Device peripheral nerve stimulation.Participants will not receive a cutaneous stimuli in response to oxygen desaturations in postoperative surgical patients.
Treatment:
Device: Stimulator sham Device

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems